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Synopsis
Thrombospondins (TSPs) are evolutionarily-conserved, secreted glycoproteins that interact with cell surfaces and
extracellular matrix (ECM) and have complex roles in cell interactions. Unlike the structural components of the ECM
that form networks or fibrils, TSPs are deposited into ECM as arrays of nanoscale puncta. The cellular and molecular
mechanisms for the patterning of TSPs in ECM are poorly understood. In the present study, we investigated whether
the mechanisms of TSP patterning in cell-derived ECM involves actin cytoskeletal pathways or TSP oligomer state. From
tests of a suite of pharmacological inhibitors of small GTPases, actomyosin-based contractility, or actin microfilament
integrity and dynamics, cytochalasin D and jasplakinolide treatment of cells were identified to result in altered ECM
patterning of a model TSP1 trimer. The strong effect of cytochalasin D indicated that mechanisms controlling puncta
patterning depend on global F-actin dynamics. Similar spatial changes were obtained with endogenous TSPs after
cytochalasin D treatment, implicating physiological relevance. Under matched experimental conditions with ectopically-
expressed TSPs, the magnitude of the effect was markedly lower for pentameric TSP5 and Drosophila TSP, than for
trimeric TSP1 or dimeric Ciona TSPA. To distinguish between the variables of protein sequence or oligomer state, we
generated novel, chimeric pentamers of TSP1. These proteins accumulated within ECM at higher levels than TSP1
trimers, yet the effect of cytochalasin D on the spatial distribution of puncta was reduced. These findings introduce
a novel concept that F-actin dynamics modulate the patterning of TSPs in ECM and that TSP oligomer state is a key
determinant of this process.
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INTRODUCTION
Thrombospondins (TSPs) are an evolutionarily conserved family
of large, calcium-binding glycoproteins. Designated as matri-
cellular proteins, they are secreted and perform a diverse range
of functions through interactions with the extracellular matrix
(ECM), the cell surface and, indirectly, with the actin cytoskel-
eton [1–6]. TSPs have a substantial clinical significance with
associations with both genetic and acquired human diseases.
For example, mutations in TSP5 are causal in pseudoachron-
droplasia (PSACH) [7–9] and single nucleotide polymorphisms
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(SNPs) identified in TSP1 and 4 have been linked to familial
cardiovascular diseases [10–12]. In addition to familial diseases,
the up-regulation of TSP1 or TSP2 has been shown to inhibit
tumour growth through suppression of angiogenesis [13,14].
TSPs perform many of their roles through interaction with, and
deposition into, the ECM and the presence of TSPs in ECM
in vivo is well documented. For example TSP1 or TSP2 are
up-regulated in ECM during wound repair, fibrotic responses
and tumorigenesis and have roles in angiogenesis, platelet ag-
gregation and the inflammatory response [1,13]. TSP5 is largely
expressed in connective tissue and functions in cartilage ECM
assembly [1,15].
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Mammalian TSPs consist of five family members (TSP1–
TSP5) of two sub-types, either homo-trimers (TSP1, TSP2) or
homo-pentamers (TSP3, TSP4, TSP5) [1,16]. Although contain-
ing variable N-terminal regions, mammalian TSPs share com-
mon C-terminal regions that consist of three or four EGF-like
domains, a series of calcium-binding type 3 repeats and a glob-
ular L-lectin-like domain [16–19]. The deposition of TSP1 into
ECM is mediated by its C-terminal region in trimeric form [20].
ECM retention is a conserved property of TSPs and, for the TSPs
analysed to date, involves the deposition of characteristic insol-
uble puncta into cell-derived ECM. These punctate structures are
relevant to the in vivo ECM patterning of TSPs [20].
Extracellular TSP1 is known to regulate actin microfilament
(F-actin) organization in multiple ways that promote cell motil-
ity [21]. TSP1 regulates the adherence of fibroblasts and en-
dothelial cells to a fibronectin ECM through the disassembly
of focal adhesions and F-actin bundles [22]. Soluble TSP1 reg-
ulates the phosphoinositol 3-kinase and cyclic-GMP-dependent
kinase-dependent release of α-actinin and vinculin from adhesion
plaques, a property that weakens cell–ECM attachment [23,24].
Cell spreading and migration on TSP1 substrata is associated
with the formation of extensive lamellipodia [25]. TSP1 mod-
ulates F-actin organization through the actin-bundling protein
fascin-1, leading to the formation of large lamellipodia with ribs,
microspikes and filopodia that contain fascin-1 [26,27].
In contrast, very little is known about the mechanism for de-
position of TSP puncta into ECM or if the actin cytoskeleton
participates in these mechanisms. Nevertheless, a role for the
actin cytoskeleton appears possible. For other ECM compon-
ents such as fibronectin, extracellular fibril formation depends on
actomyosin-based contractility [28–32]. Elevated ECM depos-
ition of TSP1 or TSP2 is associated with situations of increased
tissue stiffness, such as in fibrosis or atherosclerotic plaques; in
these contexts, intracellular tensile forces are also increased [33].
The β1 integrin ECM adhesion receptors, which are linked indir-
ectly to F-actin, are not essential for ECM deposition of TSP1,
but increase the efficiency of its accumulation in ECM [20].
Our goal in the present study was to establish whether the
actin cytoskeleton participates in the mechanism of TSP de-
position into ECM and to analyse the contributions of various
actin cytoskeletal pathways. We establish for the first time that
F-actin integrity is important for the patterning of TSP puncta
and demonstrate the relative importance of TSP oligomer state
compared with protein sequence in this activity. These studies ad-
vance knowledge of the molecular and cell-dependent processes
that modulate ECM accumulation of TSPs.
EXPERIMENTAL
Materials and cell culture
Membrane-permeable C3 transferase was from Cytoskeleton,
Inc. Cytochalasin D, nocodazole, lysophosphatidic acid and
FITC-phalloidin were from Sigma. All other pharmacological re-
agents were from Calbiochem. The following mouse monoclonal
antibodies were used: to V5 epitope (GKPIPNPLLGLDST; [34];
Invitrogen); to FLAG epitope (M2 clone; Sigma); to DsRed
(Clontech or Abcam); to β-tubulin (Sigma); to TSP1 (A6.1; Neo-
markers). Rabbit monoclonal to COMP (EPR6289(2)) was from
Abcam, FITC-conjugated goat polyclonal IgG to V5 tag was from
Abcam. Alkaline phosphatase-conjugated secondary antibodies
were from Applied Biosystems and FITC-conjugated secondary
antibodies were from Sigma. COS7, SW480 human colon car-
cinoma and rat chondrosarcoma (RCS) cells (A.T.C.C.) were all
cultured in Dulbecco’s modified Eagle’s medium (DMEM) con-
taining 10 % fetal calf serum (FCS) in a humidified, 5 % CO2
incubator at 37 ◦C.
Thrombospondin expression plasmids
pCEP-pu plasmid was as described [17]. mRFPovTSP1C (mono-
meric RFP), TSP1.V5, TSP5.V5, D-TSP.V5 and Ci-TSPA.V5
were as described [20]. p3XFLAG-Myc-CMV-23 plasmid con-
taining a Met-preprotrypsin leader sequence was obtained from
Sigma–Aldrich. Oligonucleotide primers used to generate addi-
tional constructs within this plasmid and pCEP-pu are listed in
Table 1 and were synthesized by Sigma–Aldrich.
Transfection and analysis of ECM accumulation
COS-7 cells (2 × 105) were transiently transfected with 2.5 μg of
the indicated plasmids using Polyfect transfection reagent (Qia-
gen) according to manufacturer’s instructions. After overnight
incubation, the cells from each transfection were replated on
to glass coverslips in two replicate dishes or wells and incub-
ated for 3 days to allow for secretion and deposition of ECM.
One dish was then rinsed twice in 3× PBS and fixed in 2 %
paraformaldehyde (Electron Microscopy Sciences) for 10 min.
These cells were used to quantify the percentage of cells ex-
pressing the protein. The parallel dish was treated with 20 mM
ammonium hydroxide for 5 min to remove all cellular material
except the insoluble ECM [35], rinsed 5× in double distilled H2O
and fixed in 2 % paraformaldehyde for 10 min. In experiments
with inhibitors, 18–20 h after transfection, COS7 cells were re-
plated on glass coverslips for 2 h and then treated with either
0.5 μM jasplakinolide, 5 μM cytochalasin D, 0.5 μg/ml paclit-
axol or nocodazole, 230 ng/ml membrane permeable C3, 10 μM
Y27362, 100 μM NSC23766, 10 ng/ml toxin B or 1 μg/ml LPA
(lysophosphatidic acid) for 18 h before processing. SW480 and
RCS cells were treated with 2.5 μM (SW480) or 1 μM (RCS)
cytochalasin D, 2 and 24 h post-plating respectively. The concen-
trations of these agents were established in pilot dose-response
experiments to perturb the relevant cytoskeletal system without
preventing cell attachment or reducing cell viability over an 18 h
period.
The coverslips from cultures expressing mRFP-tagged pro-
teins were mounted directly on slides with Vectashield mounting
medium containing DAPI (Vector Laboratories). Other samples
were processed for indirect immunofluorescence before mount-
ing. To verify the absence of cellular material after ECM isolation,
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Table 1 DNA oligonucleotide primers used in the present study
Oligonucleotides DNA Sequence 5′– 3′
TSP5 coiled coil
690F GATCAAGCTTGGACAGGGCCAGAGC
644R GTACGTTAACTAGGTTACCCAGGGGCCGCACGCTGGGTAGGCC
TSP1C
445F GTACGTTAACATTGATGGATGCCTGTCCAAT
446R GTACCTCGAGTTAGGGATCTCTACATTCGTA
TSP-5-1C
690F GATCAAGCTTGGACAGGGCCAGAGC
446R GTACCTCGAGTTAGGGATCTCTACATTCGTA
FLAG–mRFP–TSP-5-1C
787F GATCGAATTCAATGGCCTCCTCC
779R GTACTCTAGATTAGGGATCTCTACATTCGTATTTCAGG
FLAG–TSP1C
688F GATCAAGCTTATTGGCCACAAGACA
779R GTACTCTAGATTAGGGATCTCTACATTCGTATTTCAGG
FLAG–TSP-5-1C
690F GATCAAGCTTGGACAGGGCCAGAGC
779R GTACTCTAGATTAGGGATCTCTACATTCGTATTTCAGG
samples were stained with DAPI as a nuclear stain. A minimum
of two coverslips were scored for each sample in each experiment
and a minimum of three independent experiments were carried
out for each experimental condition.
Analysis of TSP proteins by SDS/PAGE and
immunoblot
TSP proteins were collected from conditioned media 2 days after
transfection, using either RFP-Trap_A beads for RFP-tagged
proteins (Chromotek) or immunoprecipitation with anti-FLAG
monoclonal antibody M2 (Sigma) bound to rProtein G Agarose
beads (Invitrogen) for the FLAG-tagged proteins. Thirty micro-
litre of packed bead slurry bound to 2 μg of antibody was incub-
ated with 3 ml of conditioned media containing complete protease
inhibitor cocktail (Roche) for 3 h at 4 ◦C before centrifugation
and washing three times in Tris-buffered saline containing 2 mM
CaCl2. Proteins were eluted from the beads by boiling in SDS
sample buffer with or without 100 mM DTT. SDS/PAGE under
reducing or non-reducing conditions followed by immunoblot-
ting was carried out as described [36].
Fluorescence microscopy, scoring and image
analysis
ECM samples for widefield fluorescence microscopy were ex-
amined under a Leica DMIRE2 inverted microscope (Heidel-
berg), equipped with electronically controlled shutters and fil-
ter wheel. Images were captured under a Leica HCX Pl Apo
63×/N. A. 1.32 Oil Ph 3 Cs objective lens using a Hamamatsu
camera controller C4742_95 run by Leica Applications Systems
software (version 3.1.5). Cellular samples were examined un-
der a Leica SP5-AOBS confocal laser scanning microscope with
HCX Plan Apo 100× N.A.1.4 oil immersion objective lens, us-
ing Leica confocal software version 2.5. Confocal images were
acquired as XY sections at zoom 1, at room temperature. The
percentage of transfected cells expressing the protein of interest
was calculated in each experiment by direct scoring of cells ex-
pressing mRFP-tagged proteins as a fraction of DAPI-stained
nuclei or by permeabilization in 0.5 % Triton X-100 and indir-
ect immunofluorescent staining with appropriate antibodies for
the non-RFP-tagged proteins. Ten to twenty 63× fields were
scored per coverslip. To quantify ECM retention of the various
proteins, the total number of arrays of puncta/63× field and the
number of arrays with an edge concentrated pattern of puncta,
were scored from 10–30 fields per coverslip. For SW480 cells,
individual arrays were scored from four separate experiments
and four coverslips per experiment. In all experiments, the per-
centage of arrays with edge concentrated puncta was quantified.
To quantify the pixel intensity across an array of puncta, a line
was drawn across the centre of an array from a representative
fluorescence image in ImageJ 1.46v (Figure 1B). Using the Plot
Profile function, the pixel intensity along the line was measured
and plotted against distance along the line. To compare between
lines of different total lengths, the total length of the line for each
array was normalized to 1.
RESULTS
Identification of a role for F-actin in the patterning
of TSP1 within ECM
TSPs are deposited into cell-derived ECM as arrays of fine puncta
[20]. How this patterning is regulated by cells is not understood.
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Figure 1 Effect of cytochalasin D and nocodazole on ECM patterning of mRFPovTSP1C
(A) Representative fluorescence images of ECM deposition patterns of mRFPovTSP1C after treatment of cells with vehicle
(DMSO), 0.5 μM cytochalasin D or 0.5 μg /ml nocodazole for 18 h. (B) Representative fluorescence images from (A) used
to determine fluorescence intensity across array. Line used to measure relative distance across each array is shown. (C)
Line scan of fluorescence intensity across fluorescence images shown in (B) using the plot profile function on ImageJ.
(version 1.46r). To compare between images, the total line distance for each image was normalized to 1. (D) Immunoblots
of TALON-pulldowns from conditioned media (CM) and ammonium hydroxide-extracted ECM, from an equal number of COS7
cells transfected with the indicated constructs, treated with either cytochalasin D or DMSO (UT). (E) Quantification of RFP
signal from CM and ECM of COS7 cells transfected with the indicated constructs, from two immunoblots. Proteins were
resolved on 10 % SDS/PAGE gels under reducing conditions. Molecular mass markers are in kDa. Columns represent the
mean and bars indicate S.E.M. from two independent experiments.
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To establish whether cytoskeletal organization contributes to the
patterning of TSP1 within ECM, we tested the effects of phar-
macological perturbations of the F-actin or microtubule cyto-
skeletons on the ECM retention of a model, fluorescently-tagged
mini-trimer, mRFPovTSP1C. This engineered, trimeric protein
contains the domains of TSP1 that are necessary and sufficient
for ECM accumulation [20]. Because the goal of the experiments
was to investigate effects on deposition into the insoluble ECM,
pilot dose-response experiments established the minimum con-
centrations of the agents that were effective for perturbation of the
relevant cytoskeletal system without preventing cell attachment
or reducing cell viability over the time period needed for ECM
accumulation of TSP1 to a sufficient level for quantified scor-
ing, typically 18–24 h. In the final protocol to examine effects on
patterning of newly deposited mRFPovTSP1C, cells were trans-
fected, incubated for 18 h for protein expression, re-plated on to
glass coverslips for 2 h for cell attachment and then incubated
in the presence of the pharmacological agents for 18 h. Parallel
samples were then processed either by fixation for scoring of
cell numbers and cell morphology or by ammonium hydroxide
extraction to isolate the insoluble cell-derived ECM [20].
Under control conditions, mRFPovTSP1C accumulates in
ECM as arrays of relatively uniformly spaced small puncta (Fig-
ure 1A, + DMSO panel). Cytochalasin D that inhibits actin poly-
merization by binding to F-actin barbed ends [37], had a striking
effect on the ECM patterning of mRFPovTSP1C puncta, such that
puncta were deposited non-uniformly and concentrated around
the edges of the puncta arrays (Figure 1A, + CytoD panel). In
contrast, nocodazole, which depolymerizes microtubules, did not
alter the patterning of puncta as compared with control conditions
(Figure 1A, + Noc panel). The quantitative change in patterning
after cytochalasin D treatment of cells was demonstrated by lin-
escan plots of fluorescence intensity across the arrays, (examples
shown in Figures 1B and 1C). Both inhibitors resulted in reduced
cell spreading and each inhibitor had its expected effect on F-actin
or microtubule integrity respectively (Supplementary Figure S1).
Because nocodazole treatment also resulted in cell rounding but
did not alter the pattern of deposition of mRFPovTSP1C, we infer
that the effect of cytochalasin D was not a consequence of cell
rounding per se.
Cytochalasin D did not reduce the amount of mRFPovTSP1C
in the conditioned media of transfected cells (Figures 1D and
1E) nor did it alter the accumulation of mRFPovTSP1C in the
ECM compared with the control condition (Figures 1D and 1E).
A trimeric mRFPo control protein was secreted into the media
but, as expected, did not accumulate in the ECM (Figure 1D
and 1E). Thus, the altered patterning of mRFPovTSP1C within
ECM appeared to result from a functional effect of altered actin
cytoskeletal organization on post-secretion processes.
Alterations in ECM patterning of mRFPovTSP1C are
linked specifically to F-actin dynamics
To investigate the molecular basis for this action of cytochalasin
D, additional pharmacological agents that perturb F-actin stress
fibres or actin-associated proteins, including inhibitors or ac-
tivators of members of the Rho family of small GTPases, the
Rho/Rho kinases pathway and actomyosin contractility, were
tested in comparison with cytochalasin D. Effects on puncta
patterning in ECM were quantified from multiple experiments.
None of the pharmacological agents markedly affected the ex-
pression of mRFPovTSP1C by the transfected cells (Figure 2A).
Blebbistatin, an inhibitor of myosin ATPase or ML-7, an inhib-
itor of myosin light chain kinase, did not alter the patterning
of mRFPovTSP1C within ECM (Figure 2B). Hyper-activation
of Rho GTPase by treatment of cells with LPA, inhibition of
Rho with membrane-permeable C3-transferase or inhibition of
Rho kinases with Y27632, similarly did not alter the pattern-
ing of mRFPovTSP1C puncta (Figure 2B). Clostridium difficile
Toxin B that inhibits multiple Rho family small GTPases [38]
and NSC23766 that specifically inhibits Rac [39] did not alter
the patterning of puncta (Figure 2B). It should be noted that
some of these treatments reduced the level of mRFPovTSP1C
present in the conditioned media (Figures 2C and 2D); however,
in all cases, sufficient mRFPovTSP1C accumulated in ECM for
effects on ECM patterning to be detected. Overall, these find-
ings led us to focus specifically on mechanisms of global F-actin
assembly and dynamics.
Latrunculin B reduces F-actin levels indirectly, by binding and
sequestration of G-actin monomers [40], whereas jasplakinolide
stabilizes F-actin and promotes the rate of actin filament nucle-
ation [41,42]. Latrunculin B treatment, although effective for loss
of F-actin (Supplementary Figure S1), did not alter the pattern-
ing of mRFPovTSP1C puncta (Figures 3A and 3C). However,
jasplakinolide treatment, which resulted in cell rounding (Sup-
plementary Figure S1), elevated the proportion of ECM arrays of
mRFPovTSP1C that had edge-concentrated puncta, although to a
lesser extent than cytochalasin D (Figures 3A and 3C). Treatment
of cells with either latrunculin B or jasplakinolide did not alter
the proportion of mRFPovTSP1C-expressing cells (Figure 3B).
Because both cytochalasin D and jasplakinolide act directly on
F-actin, albeit by differing mechanisms, these findings indicated
that TSP1 puncta patterning might depend on F-actin dynamics.
The drug cocktail consisting of jasplakinolide, latrunculin B and
Y27632 is reported to be very effective in ‘freezing’ the actin
cytoskeleton [43]. This idea was investigated further by testing
double or triple combinations of jasplakinolide, latrunculin B
and Y27632 for effects on mRFPovTSP1C patterning within the
ECM. However, even the triple combination of jasplakinolide,
latrunculin B and Y27632 together did not alter ECM patterning
of mRFPovTSP1C to a greater extent than jasplakinolide alone
(result not shown).
Relationship of F-actin dynamics to ECM patterning
of endogenous thrombospondins
Having established a role of F-actin dynamics in ECM patterning
of ectopically expressed mRFPovTSP1C, we next wanted to ask
whether the ECM patterning of endogenous TSP also demon-
strates a relationship with F-actin dynamics. Pilot experiments
determined that SW480 human colon carcinoma cells secrete
TSP1 and RCS cells secrete TSP5. Each cell line was tested
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Figure 2 Effects of inhibitors of actin or actin-related pathways on ECM patterning of mRFPovTSP1C
(A) Quantification of mRFPovTSP1C expressing cells after treatment with various inhibitors for 18 h. (B) Quantification
of ECM deposition patterns after treatment with the various inhibitors for 18 h. (C and D) Levels of mRFPovTSP1C
present in conditioned media (CM): (C) or total cell lysate (TCL) (D) after treatment of transfected cells with the various
inhibitors for 18 h. Proteins were resolved on 10 % SDS/PAGE gels under reducing conditions. Molecular mass markers
are in kDa. In (A and B), columns represent the mean and bars indicate S.E.M. from three independent experiments.
***P< 0.001.
with a range of cytochalasin D concentrations, to determine the
specific conditions under which F-actin organization would be
disrupted without preventing cell attachment or reducing cell vi-
ability over the time period of the experiment. SW480 cells under
control conditions exhibit both round and extended shapes due
to their high cell motility [44]. Treatment of SW480 cells with
0.25 μM cytochalasin D over 18 h resulted in a slightly increased
fraction of rounded cells (Figure 4A, bright-field images) and a
clear alteration of actin organization from microfilaments to ag-
gregates in the cells (Figure 4A, fluorescence panels). In the case
of RCS cells, to avoid loss of cells, it was necessary to allow cells
to attach for 24 h prior to treatment with 1 μM cytochalasin D.
This treatment resulted in clear rounding and reduced spreading
of RCS cells (Figure 4A, bright-field panels), with loss of actin
microfilaments (Figure 4A, fluorescence panels). Under control
conditions, TSP1 is deposited into the ECM of SW480 cells as
arrays of puncta; both round and extended shapes of arrays were
detected and this probably relates to the range of morphologies
of these cells. Examples are shown in Figure 4(B). After treat-
ment of SW480 cells with cytochalasin D, an increase in arrays
with edge-concentrated puncta was observed compared with the
DMSO controls (Figure 4B). For SW480 cells, the percentage of
arrays with edge-concentrated puncta increased from a mean of
8 % to a mean of 29 % after cytochalasin D treatment (Figure 4C).
Under control conditions, RCS cells deposit TSP5 into ECM in
the form of arrays of uniformly-spaced puncta (Figure 4D). This
patterning was dramatically changed in the ECM of cytochalasin
D-treated cells: overall, much less TSP5 was detected in ECM and
the arrays that were present all showed large TSP5 puncta at their
edges. Multiple examples are shown in Figure 4(D). The smaller
size of these arrays probably relates to the much reduced spread-
ing of RCS cells after cytochalasin D treatment. These findings
indicate that reorganization of ECM patterning of TSPs upon
cytochalasin D treatment is relevant to endogenously-expressed
TSPs.
Relationship of F-actin dynamics to ECM patterning
of other thrombospondin family members
Having established that F-actin dynamics have physiologically
relevant roles in the ECM patterning of TSPs, we examined more
widely other TSP family members, including TSPs that assemble
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Figure 3 Effect of actin-perturbing inhibitors on ECM patterning of mRFPovTSP1C
(A) Representative fluorescence images of ECM deposition patterns of mRFPovTSP1C after treatment of cells with vehicle
(DMSO), 0.5 μM cytochalasin D, 0.67 μM jasplakinolide or 0.5 μM latrunculin B for 18 h. (B) Quantification of mR-
FPovTSP1C-expressing cells under the different experimental conditions. (C) Quantification of edge-concentrated ECM
puncta under the different experimental conditions. (B and C) Columns represent the mean and bars indicate S.E.M. from
three independent experiments. ***P< 0.001.
in different oligomeric states and non-mammalian TSPs. Ciona
intestinalis TSPA assembles as a dimer [45] and Drosophila
melanogaster TSP (D-TSP), like human TSP5, is a pentameric
TSP [36,46]. To enable accurate comparison in the experiments,
the proteins were expressed under the same conditions in COS7
cells and were detected with the same antibody to the V5 tag. In
each case, whereas the majority of ECM puncta were uniformly
spaced under control conditions, an increase in ECM arrays with
ring-like patterning of puncta were observed after cytochalasin
D treatment (Figure 5A). In the absence of V5 antibody no stain-
ing was observed (Figure 5A). However, the proportion of ECM
arrays with altered puncta patterning differed markedly between
dimeric, trimeric or pentameric TSPs. Quantification over mul-
tiple independent experiments established that each protein was
expressed equivalently and the percentage of expressing cells was
not altered after cytochalasin D treatment (Figure 5B). However,
the effectiveness of cytochalasin D in bringing about the altered,
edge-concentrated patterning of puncta correlated inversely with
the oligomeric state of the TSP. Thus, the percentage of arrays
of edge-concentrated puncta was highest with dimeric C. intest-
inalis TSPA (mean of 41 %) and lowest with the pentameric TSPs
(mean of 9 % for TSP5 and 13 % for D-TSP). Nevertheless, the
frequency of edge-concentrated puncta was increased signific-
antly for all the proteins after cytochalasin D treatment compared
with the control condition (Figure 5C).
Effects of altered F-actin dynamics on ECM
patterning of an engineered TSP1C oligomer
identifies a role of oligomeric state
The above experiments demonstrated a complex relationship
between oligomer state and actin modulation and it remained
possible that protein sequence determinants, rather than oligomer
state, modulate the relationship between F-actin organization and
puncta patterning. For example, the L-lectin domain of human
TSP1 has 62 % sequence identity to that of human TSP5 and
58 % identity to the L-lectin domain of D-TSP. To differentiate
between the effects of protein sequence and oligomer state, a
chimeric TSP was engineered which contained the coiled-coil
oligomerization domain from TSP5 fused to the C-terminal re-
gion from TSP1. This construct is referred to subsequently as
TSP-5-1C (Figure 6A). To control for possible tag-specific ef-
fects, constructs with different tags were generated, one with
FLAG alone and the other with mRFP and FLAG (Figure 6A).
To assess whether these novel TSP-5-1C proteins oligomer-
ized correctly and could accumulate within ECM, these pro-
teins or a suite of control proteins, were expressed transiently
in COS7 cells and then isolated from conditioned media, with
either RFP-Trap_A beads for the mRFP-tagged proteins or anti-
FLAG immunoprecipitation for the FLAG-tagged proteins. Total
cell lysates and ECM were also collected. From the conditioned
media, each protein migrated at its expected molecular mass
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Figure 4 Effect of cytochalasin D treatment on ECM patterning of endogenous TSP proteins expressed by SW480 and
RCS cells
(A) Representative bright-field images and confocal XY sections of SW480 and RCS cells treated with either 0.25 μM
(SW480) or 1 μM (RCS) cytochalasin D or DMSO solvent only for 18 h. For confocal microscopy, cells were stained
with FITC–Phalloidin (green) and DAPI (blue) prior to imaging. (B) Representative fluorescence images of ECM deposition
patterns of endogenous TSP1 by SW480 cells, after treatment of cells with 0.25 μM cytochalasin D or vehicle (DMSO) for
18 h. An image of SW480 ECM without primary antibody is included as a control. (C) Quantification of edge concentrated
ECM puncta of endogenous TSP1 by SW480 cells, +− cytochalasin D. (D) Representative fluorescence images of ECM
deposition patterns of endogenous TSP5 by RCS cells, after treatment of cells with 1 μM cytochalasin D or vehicle
(DMSO) for 24 h. For cytochalasin D treated cells, three separate images are shown at the same scale and arrowheads
indicate circular ECM arrays. An image of RCS ECM without primary antibody is included as a control. In (C), columns
represent the mean and bars indicate S.E.M. from four independent experiments. *P< 0.05.
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Figure 5 Effect of cytochalasin D treatment on ECM patterning of different TSP family members
(A) Representative fluorescence images of ECM deposition patterns of V5-tagged TSP1, Drosophila TSP (D-TSP), TSP5
or Ciona TSPA (Ci-TSPA) after treatment of cells with vehicle (DMSO) or 0.5 μM cytochalasin D for 18 h. An image of
TSP1-V5 without primary antibody is included as a negative control. (B) Quantification of V5-expressing cells for each
protein under the different experimental conditions. (C) Quantification of edge-concentrated ECM puncta for each protein
under the different experimental conditions. (B and C) Columns represent the mean and bars indicate S.E.M. from three
independent experiments. *P< 0.05, **P< 0.01, ***P< 0.001.
when resolved by SDS/PAGE under reducing conditions (Fig-
ures 6B and 6C). When resolved under non-reducing SDS/PAGE
conditions, the FLAG–TSP-5-1C and mRFP–TSP-5-1C proteins
each migrated with higher apparent molecular mass than the re-
spective control TSP1C protein. The apparent molecular mass of
FLAG–TSP-5-1C was equivalent to that of the natural pentamer,
FLAG–TSP5 (Figure 6B). Equivalent results were obtained if the
FLAG–mRFP-tagged proteins were immunoblotted for FLAG
instead of RFP (result not shown). Thus, the chimeric proteins
are secreted by cells and oligomerize efficiently with the char-
acteristics of a pentamer. Although present within the cell layer
at similar levels to the control proteins, FLAG–TSP5-1C was
typically present in conditioned media at lower levels than the
FLAG–TSP1C or FLAG–TSP5 control proteins. A similar trend
was noted for mRFP–TSP-5-1C (Figures 6B and 6C).
Having established that the TSP-5-1C proteins oligomerize
and are secreted effectively, ECM was prepared from transfected
COS7 cells and extracted in hot SDS/PAGE sample buffer under
reducing conditions [20]. Both FLAG–TSP-5-1C and mRFP–
TSP-5-1C were detected in the ECM (Figures 6D and 6E). In-
terestingly, both proteins accumulated within ECM to a much
higher level that the respective trimeric TSP1C (Figures 6D and
6E). We infer that the lower levels in media may relate to the very
strong accumulation in ECM.
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Figure 6 Design and validation of TSP-5-1C chimeric pentamer
(A) Domain diagrams of TSP5, mRFPovTSP1C and the regions (outlined) used to construct the chimera, TSP-5-1C. FLAG-
and FLAG–RFP-tagged constructs were generated. Abbreviations: cc, coiled-coil; EGF, EGF-like domain; L-lectin, L-type lectin
domain; SP, signal peptide; SS, position of cysteines that form inter-subunit disulfide bonds; type 3, TSP type 3 repeats;
vWF_C, von Willebrand factor_type C domain. (B and D) Analysis of FLAG-tagged constructs. (B) Immunoblots of anti-FLAG
immunoprecipitates from conditioned media (CM), resolved on SDS/PAGE gels under reducing or non-reducing conditions.
(D) Immunoblots of total cell lysates (TCL) and NH4OH-isolated ECM from COS7 cells transfected with the indicated
constructs. (C and E) Analysis of FLAG–RFP tagged constructs. (C) Immunoblots of RFP-Trap pulldowns from CM. (E)
Immunoblots of total cell lysates and NH4OH extracted ECM from transfected COS7 cells. (D and E) Panels are from the
same original immunoblot. To improve the resolution of high-molecular mass proteins, proteins below 75 kDa were run off
the SDS/PAGE gel; hence, the mRFP protein was not detected in C. (B–E) All molecular mass markers are given in kDa.
The 315 kDa mass marker was from a different protein ladder run on the same gel in a separate lane.
Next, the patterning of these proteins in ECM and the effects
of cytochalasin D were examined by fluorescence microscopy.
FLAG–TSP-5-1C displayed a similar ECM patterning to FLAG–
TSP1C in the absence of cytochalasin D, with distinct fluorescent
puncta distributed quite uniformly in the ECM arrays (Figure 7A).
In the absence of FLAG antibody, no staining was observed
(Figure 7A). A similar uniform distribution of puncta was ob-
served for mRFP–TSP-5-1C in comparison with mRFPovTSP1C
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(Figure 7A). For both the TSP-5-1C proteins, the puncta tended
to be denser within the arrays than for the trimeric TSP1C (Fig-
ure 7A). The percentage of cells expressing each recombinant
protein was not altered significantly after cytochalasin D treat-
ment (Figures 7B and 7D). However, cytochalasin D treatment
resulted in a significant increase in ECM arrays with puncta con-
centrated at the edges for all proteins in comparison with the
control conditions (Figures 7C and 7E). Furthermore, the occur-
rence of edge-concentrated puncta was significantly higher for
trimeric mRFPovTSP1C or FLAG–TSP1C than for the engin-
eered pentamers (Figures 7C and 7E). These results demonstrate
that the oligomeric state of the TSP C-terminal region from TSP1
can determine the efficiency of its accumulation within ECM.
The results also show that oligomer state impacts on the respons-
iveness of ECM patterning to blockade of F-actin dynamics by
cytochalasin D.
DISCUSSION
We present here, data in support of a novel concept whereby
F-actin dynamics modulate the patterning of TSPs in the ECM
and oligomer state of the TSP is a key determinant in this pro-
cess. We demonstrate that the ECM patterning of TSPs changes
from uniform to edge-concentrated arrays of puncta after treat-
ment of cells with cytochalasin D. This effect was also seen for
endogenous TSP1 and TSP5, in support of a physiologically rel-
evant role for F-actin dynamics. Under matched experimental
conditions of ectopic expression in COS-7 cells and detection
by a V5 epitope tag, this effect was seen for human TSP1 and
TSP5, Drosophila TSP and Ciona TSPA, thus encompassing
dimeric, trimeric and pentameric oligomers and evolutionarily
distant forms of TSPs. This implicates a conserved mechanism
by which global F-actin cytoskeletal dynamics modulate the spa-
tial characteristics of ECM deposition of TSPs. The experiments
in COS7 cells also identified that the magnitude of the effect of
cytochalasin D treatment on ECM patterning correlates inversely
with TSP oligomer state. This was investigated definitively by
use of a novel, pentameric chimera between the coiled-coil oligo-
merization domain of TSP5 and the TSP1 C-terminal region that
enabled us to distinguish between effects of protein sequence and
oligomer state. The results obtained demonstrate that oligomer
state is a key determinant of F-actin-dependent ECM patterning
modulation.
Of the pharmacological inhibitors of the F-actin cytoskeleton
tested, cytochalasin D had by far the strongest effect, whereas
jasplakinolide had a mild effect and latrunculin B had none.
Cytochalasin D binds the barbed ends of actin filaments inhib-
iting both polymerization and depolymerization [37], through a
similar mode of action to jasplakinolide which binds to the side
of actin filaments [41,42]. In addition, cytochalasins have been
shown to bind actin monomers and dimers, altering the kinetics
of actin filament growth and slowing elongation [47,48]. This
effect is mimicked by latrunculin B [40]; however, latrunculin
B did not alter the patterning of mRFPovTSP1C within ECM.
Taken together, these results suggest that the combined actions of
cytochalasin D on binding to F-actin barbed ends and modulat-
ing F-actin dynamics by altering the nucleation pool available for
microfilament elongation is the most likely reason for its striking
effect on the ECM patterning of TSPs.
With regard to ECM retention of TSPs as a cell-mediated
process, we note interesting differences in the role of the actin
cytoskeleton compared with structural ECM components such
as fibronectin. In the case of fibronectin matrix assembly, Rho-
dependent, actomyosin-based contractility is essential for con-
formational changes that enable fibrillogenesis from cell-surface
bound fibronectin dimers [30–32]. In contrast, the patterning
of TSP puncta depended strongly on polymerized actin but
was not markedly altered by changes to actomyosin contractil-
ity or Rho-dependent signalling. A specific role of the Rho
pathway in puncta patterning was not detected; however, per-
turbation of the Rho pathway did decrease the secretion of
mRFPovTSP1C.
The differential responsiveness of natural TSPs of different
oligomer states to altered F-actin dynamics may relate to the
different tissue contexts and expression patterns of TSP family
members [1]. TSP5 is expressed throughout life in cartilage and
tendon, tissues that undergo major deformation and in which cells
are exposed constantly to a range of tensile stresses [1,49,50].
Similarly, D-TSP is present at muscle–tendon attachment sites
[51,52]. In contrast, TSP1 is at very low levels in most adult
tissues and becomes elevated in ECM in situations of tissue re-
modelling or fibrosis, in which F-actin cytoskeletal organization
in cells may be altered or undergoing dynamic changes as cells
migrate [21]. For example, TSP1 is elevated in atherosclerotic
plaques and is an inducer of smooth muscle cell migration and
proliferation [33,53–55]. The greater sensitivity of ECM pattern-
ing of trimeric TSP1 to altered F-actin dynamics may assist the
co-ordination of changes in cell behaviour with spatiotemporal
variations in ECM microenvironment.
The inverse correlation between responsiveness of ECM pat-
terning to altered F-actin dynamics and higher order oligomer
state of TSPs was investigated definitively by use of a chimeric
construct that fused the coiled-coil oligomerization domain from
TSP5 with the C-terminal region of TSP 1. This increase in
oligomer state sharply increased the level of ECM deposition
(Figures 6D, 6E and 7A). In contrast, the effect of cytochalasin
D treatment on the ECM patterning of TSP-5-1C was decreased
in comparison with mRFPovTSP1C. So, whereas the chimeric
protein accumulates in ECM to a greater extent, the influence of
F-actin dynamics on ECM patterning is diminished, representing
two separate facets of the functional significance of oligomer state
over sequence-specific activity for TSPs. All experiments using
the chimera were performed with two different tagged constructs,
reducing the possibility of tag-specific artifacts. We note that a
contribution of protein sequence to the functional response is not
excluded, since pentameric TSP5 showed more limited alteration
of patterning than D-TSP (Figure 4). The results implicate that a
common, actin-dependent, modulatory mechanism can function
in distinct ways for the different forms of TSPs.
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Figure 7 Effect of cytochalasin D treatment on ECM patterning of TSP1C proteins of different oligomer state
(A) Representative fluorescence images of ECM deposition patterns of TSP1C or TSP-5-1C, after treatment of cells
with 0.5 μM cytochalasin D or vehicle (DMSO) for 18 h. Shown for both FLAG- and RFP-tagged proteins. An image of
FLAG–TSP1C without primary antibody is included as a control. (B and D) Quantification of expressing cells for FLAG- (B)
or RFP-tagged (D) constructs +− cytochalasin-D. (C and E) Quantification of edge concentrated ECM puncta for FLAG–TSP1C
(C) or mRFP–TSP-5-1C (E), +− cytochalasin D. (B–E) Columns represent the mean and bars indicate S.E.M. from three
independent experiments. *P< 0.05, **P< 0.01, ***P< 0.001.
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In future, it will be of interest to examine further the cellu-
lar mechanisms that lead to edge-concentration of TSP puncta
arrays within ECM, in particular whether this relates to spatially-
restricted trafficking and secretion of TSP-containing vesicles,
specific aspects of the association of vesicles with F-actin or to
the localization of cell-surface or ECM-located TSP-binding pro-
teins. The TSP-5-1C chimeras will be useful tools to investigate
the influence of sequence compared with oligomer state for the
range of TSP1 functions that span from effects on cell phenotype
and migration to ECM organization.
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